| AIB Phase II group | CVD group | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Haplotypes | Freq | Haplotype scoreb | p-value | Haplotype scoreb* | p-value* | Hypertensive freq | Non-hypertensive freq | Haplotype scoreb | p-value | Haplotype scoreb†| p-value†|
EVEa | 50.5% | 0.497 | 0.62 | 0.392 | 0.70 | 53.5% | 54.4% | -0.578 | 0.56 | -0.715 | 0.47 |
KVGa | 22.0% | 0.638 | 0.52 | 0.629 | 0.51 | 18.0% | 17.8% | 0.206 | 0.84 | 0.433 | 0.66 |
KVEa | 21.2% | -0.669 | 0.50 | -0.687 | 0.49 | 21.5% | 21.7% | -0.004 | 0.99 | -0.073 | 0.94 |
EMEa | 6.3% | -0.954 | 0.34 | -0.725 | 0.45 | 7.0% | 6.1% | 0.921 | 0.36 | 0.948 | 0.34 |
Overall p-value | Â | 0.65 | 0.73 | Â | Â | 0.80 | 0.79 |